Gene:
CACNB2
calcium channel, voltage-dependent, beta 2 subunit

Overview

Alternate Names: OTTHUMP00000019254; OTTHUMP00000019255; OTTHUMP00000019256; OTTHUMP00000196786; myasthenic (Lambert-Eaton) syndrome antigen B
Alternate Symbols: CACNLB2; CAVB2; FLJ23743; MYSB
PharmGKB Accession Id: PA88

Details

Cytogenetic Location: chr10 : p12.33 - p12.31
GP mRNA Boundary: chr10 : 18469612 - 18870045
GP Gene Boundary: chr10 : 18459612 - 18873045
Strand: plus
Product Name: calcium channel, voltage-dependent, beta 2 subunit, calcium channel, voltage-dependent, beta 2 subunit isoform 1, calcium channel, voltage-dependent, beta 2 subunit isoform 2, calcium channel, voltage-dependent, beta 2 subunit isoform 3, calcium channel, voltage-dependent, beta 2 subunit isoform 4, calcium channel, voltage-dependent, beta 2 subunit isoform 5, calcium channel, voltage-dependent, beta 2 subunit isoform 6, calcium channel, voltage-dependent, beta 2 subunit isoform 7, calcium channel, voltage-dependent, beta 2 subunit isoform 8, myasthenic (Lambert-Eaton) syndrome antigen B
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

Non-Curated Information

A list of non-curated publications that mention this gene along with other genes is available.

PharmGKB Curated Pathways

Non-Curated Information

A list of non-curated publications that mention this gene along with other drugs is available.

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (GM61374).
©2001-2010 PharmGKB.